Usefulness of serum interleukin-18 in predicting cardiovascular mortality in patients with chronic kidney disease-systems and clinical approach

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Formanowicz, Dorota ^a   Wanic Kossowska, Maria ^a   Pawliczak, Elzbieta ^a   Radom, Marcin ^b   Formanowicz, Piotr ^b,c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNAN UNIVERSITY OF TECHNOLOGY   (Poland)

^c INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 18; INTERLEUKIN 18 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC PLAQUE; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PATHOLOGY; PREDICTIVE VALUE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84950255202     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18332     Document Type: Article

References (30)

1. McCullough, P. A., Agrawal, V., Danilewicz, E., Abela, G. S. Accelerated Atherosclerotic Calcification and Mönckeberg's Sclerosis: A Continuum of Advanced Vascular Pathology in Chronic Kidney Disease. CJASN 3, 1585-1598 (2008).
2. Gansevoort, R. T. et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382, 339-352 (2013).
3. Schwarz, U. et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol. Dial. Transplant. 15, 218-223 (2000).
4. Luczak, M. et al. Chronic kidney disease-related atherosclerosis-proteomic studies of blood plasma. Proteome Sci. 9, 25 (2011).
5. Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., Murphy, K. M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688 (2006).
6. Kurts, C., Panzer, U., Andres, H.-J., Rees, A. The immune system and kidney disease: Basic concepts and clinical implications. Nat. Rev. Immunol. 13, 738-753 (2013).
7. Mallat, Z. et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104, 1598-1603 (2001).
8. Hulthe, J. et al. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 188, 450-454 (2006).
9. Liu, Y. W. et al. Elevated serum interleukin-18 level is associated with all-cause mortality in stable hemodialysis patients independently of cardiac dysfunction. PLoS One 9, e89457 (2014).
10. Porako, T. et al. IL-18 is involved in vascular injury in end-stage renal disease patients. Nephrol. Dial. Transplant. 24, 589-96 (2009).
11. Chiang, C. K. et al. Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients. Nephrol. Dial. Transplant. 19, 2810-2815 (2004).
12. Tedgui, A., Mallat, Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86, 512-581 (2006).
13. Biet, F., Locht, C., Kremer, L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J. Mol. Med. 80, 147-62 (2002).
14. Ranjbaran, H. et al. An inflammatory pathway of IFN-production in coronary atherosclerosis. J. Immunol. 178, 592-604 (2007).
15. Vanholder, R., Van Laecke, S., Glorieux, G. What is new in uremic toxicity Pediatr. Nephrol. 23, 1211-1221 (2008).
16. Mallat, Z. et al. Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure. FASEB J 18, 1752-1754 (2004).
17. Seta, Y. et al. Interleukin 18 in Acute Myocardial Infarction. Heart 84, 668-669 (2000).
18. Youssef, A. A. et al. Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ. J. 71, 703-708 (2007).
19. Di Somma, S. et al. IL-18 stimulates B-type natriuretic peptide synthesis by cardiomyocytes in vitro and its plasma levels correlate with B-type natriuretic peptide in non-overloaded acute heart failure patients. Eur. Heart J. Acute Cardiovasc. Care (2013) [doi: 10.1177/2048872613499282].
20. Cordero-Reyes, A. M. et al. IL-18 a powerful activator of B-cells is associated with mortality in acute decompensated heart failure. Circulation 130, A19229 (2014).
21. Akdag, I. et al. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin. Pract. 108, 99-105 (2008).
22. Yamaoka-Tojo, M. et al. C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome. Heart Vessels. 18, 183-187 (2003).
23. Novick, D. et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 14, 334-342 (2001).
24. Mallat, Z. et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res. 89, 41-45 (2001).
25. Thompson, S. R. et al. Free interleukin-18 levels, and the impact of IL-18 and ILBP genetic variation in CHD patients and healthy men. Atheroscler Thromb Vas Biol. 27, 2743-2749 (2007).
26. Luczak, M. et al. Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry. J. Transl. Med. 13, 20 (2015).
27. Murata, T. Petri nets: properties, analysis and applications. Proc. IEEE 90, 541-580 (1989).
28. Formanowicz, D., Kozak, A., Gowacki, T., Radom, M., Formanowicz, P. Hemojuvelin-hepcidin axis modeled and analyzed using Petri nets. J. Biomed. Inform. 46, 1030-1043 (2013).
29. Sackmann, A., Heiner, M., Koch, I. Application of Petri net based analysis techniques to signal transduction pathway. BMC Bioinformatics 7, 482 (2006).
30. Formanowicz, D., Sackmann, A., Kozak, A., Baewicz, J., Formanowicz, P. Some aspects of the anemia of chronic disorders modeled and analyzed by petri net based approach. Bioprocess Biosyst. Eng. 34, 581-95 (2011).